Follow and like us on our Facebook page where we post on the new release subject and answering tips and tricks to help save your time so that you can never feel stuck again.
Shortcut

Ctrl + F is the shortcut in your browser or operating system that allows you to find words or questions quickly.

Ctrl + Tab to move to the next tab to the right and Ctrl + Shift + Tab to move to the next tab to the left.

On a phone or tablet, tap the menu icon in the upper-right corner of the window; Select "Find in Page" to search a question.

Share Us

Sharing is Caring

It's the biggest motivation to help us to make the site better by sharing this to your friends or classmates.

Walking Pneumonia: Causes and Trends

Walking pneumonia is a mild lung infection caused by bacteria or viruses, often leading to coughing, fever, and fatigue, treatable with antibiotics.

walking

pneumonia

causes

symptoms

treatment

prevention

health

respiratory

infection

bacteria

viral

antibiotics

coughing

fever

chest

What is the role of chemotherapy in treating Triple-Negative Breast Cancer?

  • Chemotherapy is the primary treatment for TNBC.
  • Chemotherapy is used only after surgery.
  • Chemotherapy is not effective for TNBC.
  • Chemotherapy is used for advanced TNBC only.

What is the function of HER2 receptors in breast cancer cells?

  • To bind to estrogen and progesterone.
  • To make breast cancer cells less aggressive.
  • To promote cancer cell growth in HER2-positive cancers.
  • To reduce tumor size.

Which of the following is NOT typically used to treat Triple-Negative Breast Cancer?

  • Chemotherapy.
  • Hormone therapy.
  • Radiation therapy.
  • Surgery.

What is the most common symptom of Triple-Negative Breast Cancer?

  • Pain in the breast.
  • Swelling in the breast.
  • A lump in the breast.
  • Discharge from the nipple.

Which of the following is a common chemotherapy drug used for Triple-Negative Breast Cancer?

  • Tamoxifen.
  • Taxanes (like paclitaxel).
  • Herceptin.
  • Aromatase inhibitors.

Which of the following is a challenge in treating Triple-Negative Breast Cancer?

  • Lack of effective treatments.
  • Lack of targeted therapies.
  • Poor prognosis.
  • All of the above.

What is a major limitation of using chemotherapy alone for Triple-Negative Breast Cancer?

  • Chemotherapy is ineffective for TNBC.
  • Chemotherapy can cause resistance in TNBC cells.
  • Chemotherapy alone has a lower success rate compared to combined treatments.
  • Chemotherapy cannot target HER2 receptors.

Which of the following is a common treatment side effect of chemotherapy for Triple-Negative Breast Cancer?

  • Loss of appetite.
  • Hair loss.
  • Fatigue.
  • Increased appetite.

What is the general treatment approach for Triple-Negative Breast Cancer?

  • Hormone therapy.
  • Immunotherapy.
  • Surgery, chemotherapy, and radiation.
  • Only chemotherapy.

Which ethnic group is at higher risk for Triple-Negative Breast Cancer?

  • Caucasians.
  • Asians.
  • African Americans.
  • Latinas.

Which of the following is NOT a typical symptom of Triple-Negative Breast Cancer?

  • Lump in the breast.
  • Pain in the breast.
  • Sudden weight loss without cause.
  • Swelling of the breast.

What is one of the key concerns with chemotherapy for Triple-Negative Breast Cancer?

  • It can target specific receptors.
  • It has fewer side effects than other treatments.
  • It can cause serious side effects and long-term health issues.
  • It works well for all stages.

Which of the following is a potential benefit of participating in a clinical trial for Triple-Negative Breast Cancer?

  • Access to new therapies that may be more effective.
  • Potential to benefit from new experimental treatments.
  • Opportunity to avoid chemotherapy.
  • More chances of survival with no treatment.

What is the most common imaging technique used to detect Triple-Negative Breast Cancer?

  • Mammography.
  • MRI.
  • Ultrasound.
  • CT scan.

What is the likelihood of recurrence for Triple-Negative Breast Cancer?

  • High in the first 3 years after treatment.
  • Low recurrence rate.
  • Higher recurrence rate, especially within the first 5 years.
  • Recurrence is rare.

What percentage of breast cancers are classified as Triple-Negative?

  • 10-20%
  • 30-40%
  • 50-60%
  • 70-80%

What is a key reason why Triple-Negative Breast Cancer tends to be more difficult to treat?

  • It is less likely to spread.
  • It responds well to radiation therapy.
  • Lack of targeted therapies and hormonal treatments.
  • It grows slowly.

Which of the following is true about the genetic factors associated with Triple-Negative Breast Cancer?

  • Mutations in BRCA1 are linked to a higher risk.
  • BRCA mutations are not relevant.
  • Genetic testing is not recommended for TNBC.
  • TNBC is always inherited.

What is Triple-Negative Breast Cancer (TNBC)?

  • A type of breast cancer that lacks estrogen, progesterone, and HER2 receptors.
  • A cancer that is positive for estrogen, progesterone, and HER2 receptors.
  • A type of cancer found only in older women.
  • A form of breast cancer that only occurs in men.

What is the survival rate for Triple-Negative Breast Cancer compared to other types?

  • Lower survival rate.
  • Similar to other types.
  • Higher survival rate.
  • No difference.

Which treatment option is NOT typically used for Triple-Negative Breast Cancer?

  • Surgery.
  • Hormone therapy.
  • Chemotherapy.
  • Radiation.

What does "triple-negative" refer to in TNBC?

  • The absence of estrogen receptors, progesterone receptors, and HER2 protein.
  • Only the lack of estrogen receptors.
  • The presence of progesterone and HER2 receptors.
  • The presence of cancer cells in the lymph nodes.

Which of the following is a risk factor for Triple-Negative Breast Cancer?

  • Family history of breast cancer.
  • Low-fat diet.
  • High physical activity.
  • Low estrogen exposure.

Which treatment is most commonly used after surgery for Triple-Negative Breast Cancer?

  • Chemotherapy.
  • Radiation therapy.
  • Immunotherapy.
  • Hormone therapy.

What is the primary challenge with the lack of hormone receptors in Triple-Negative Breast Cancer?

  • Lack of estrogen.
  • Lack of targeted treatment options.
  • Lack of chemotherapy options.
  • Lack of radiation response.

What is the role of radiation therapy in the treatment of Triple-Negative Breast Cancer?

  • It is used to shrink tumors before surgery.
  • It is often used after surgery to reduce the risk of recurrence.
  • It is used in advanced stages only.
  • It is not typically recommended.

Can Triple-Negative Breast Cancer spread to other parts of the body?

  • No, it only stays in the breast.
  • Yes, it can spread to the lungs and liver.
  • Yes, it can spread to other organs including the lungs, liver, and brain.
  • No, it remains localized to the breast area.

What does the "triple" in Triple-Negative Breast Cancer refer to?

  • Lack of estrogen, progesterone, and HER2 receptors.
  • The three stages of cancer.
  • The number of cancerous lymph nodes.
  • The type of chemotherapy used.

What is a key factor in determining the prognosis of someone with Triple-Negative Breast Cancer?

  • Size of the tumor.
  • Stage at diagnosis.
  • Age of the patient.
  • Whether they have surgery.

What does the "negative" in Triple-Negative Breast Cancer mean in terms of receptor status?

  • The absence of cancer cells.
  • The lack of a strong immune response.
  • The absence of estrogen, progesterone, and HER2 receptors.
  • The lack of lymph node involvement.

What is the survival outlook for women diagnosed with early-stage Triple-Negative Breast Cancer?

  • Better compared to those diagnosed at later stages.
  • Similar to other types of breast cancer.
  • Worse than other types of breast cancer.
  • Less dependent on stage of diagnosis.

What is the primary reason for the aggressive nature of Triple-Negative Breast Cancer?

  • Lack of effective treatment options.
  • It is linked to genetic mutations.
  • It spreads slowly.
  • It responds well to chemotherapy.

What does the "negative" in Triple-Negative refer to?

  • The lack of estrogen, progesterone, and HER2 receptors.
  • The presence of certain genes.
  • The negative response to chemotherapy.
  • The inability to spread.

What is one of the primary reasons chemotherapy is often used for Triple-Negative Breast Cancer?

  • It is the most effective treatment.
  • It targets estrogen receptors.
  • It is one of the most effective treatments available for TNBC.
  • It works well in all stages.

What does the term "HER2" stand for in breast cancer?

  • Human Epidermal Growth Factor Receptor 2.
  • Human Epidermal Growth Factor Receptor.
  • Hereditary Estrogen Receptor.
  • Hormonal Estrogen Response.

How is Triple-Negative Breast Cancer different from other types of breast cancer?

  • It is more responsive to hormone therapy.
  • It has higher HER2 expression.
  • It lacks estrogen, progesterone, and HER2 receptors.
  • It has a better survival rate.

What is one reason why Triple-Negative Breast Cancer is more aggressive than other forms?

  • It tends to grow and spread more quickly.
  • It has higher levels of estrogen.
  • It is less likely to metastasize.
  • It responds well to treatment.

What is a common treatment option for Triple-Negative Breast Cancer?

  • Hormone therapy.
  • HER2-targeted therapy.
  • Chemotherapy.
  • Immunotherapy.

What is the role of surgery in treating Triple-Negative Breast Cancer?

  • Surgery is often used to remove the tumor.
  • Surgery is only done for advanced stages.
  • Surgery is used after chemotherapy.
  • Surgery is not typically used.

Which of the following is associated with a better prognosis for TNBC?

  • Advanced stage.
  • Early detection.
  • Tumor size larger than 5 cm.
  • Lack of chemotherapy.

At what age is Triple-Negative Breast Cancer most commonly diagnosed?

  • Under 40 years old.
  • Between 40-60 years old.
  • Over 60 years old.
  • Any age.

What role does the BRCA1 gene mutation play in the risk of Triple-Negative Breast Cancer?

  • It increases the risk of developing TNBC.
  • It decreases the risk of TNBC.
  • It has no effect on the risk.
  • It only affects the treatment options.

Which of the following is a common side effect of chemotherapy for Triple-Negative Breast Cancer?

  • Nausea and vomiting.
  • Sore throat.
  • Weight gain.
  • Increased skin pigmentation.

What is the importance of early detection in Triple-Negative Breast Cancer?

  • It reduces the need for chemotherapy.
  • It is critical for improving survival rates.
  • Early detection increases the chances of successful treatment.
  • It prevents the cancer from spreading.

Which genetic mutation is most often associated with an increased risk for TNBC?

  • BRCA1 mutation.
  • BRCA2 mutation.
  • P53 mutation.
  • KRAS mutation.

Which group has a higher risk of developing Triple-Negative Breast Cancer?

  • Older women.
  • African American women.
  • Asian women.
  • Hispanic women.

How does the absence of estrogen and progesterone receptors impact treatment for Triple-Negative Breast Cancer?

  • It limits the use of hormone therapy.
  • It makes chemotherapy more effective.
  • It increases survival rates.
  • It allows for targeted therapies to work better.

Which of the following can increase the risk of developing Triple-Negative Breast Cancer?

  • Inherited BRCA mutations.
  • High-fat diet.
  • Regular exercise.
  • Low estrogen exposure.

What is the role of immunotherapy in treating Triple-Negative Breast Cancer?

  • It is the first-line treatment.
  • Immunotherapy is a newer treatment option for advanced cases.
  • It has no effect on TNBC.
  • It is only used after chemotherapy.

What role do clinical trials play in the treatment of Triple-Negative Breast Cancer?

  • They are only used for research purposes.
  • Clinical trials offer access to new treatments and therapies.
  • They have no impact on treatment decisions.
  • Clinical trials are limited to later stages.
Comments